These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1021 related items for PubMed ID: 19015633

  • 1. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T, Fournane S, Orfanoudakis G, Travé G, Masson M.
    Oncogene; 2009 Feb 05; 28(5):762-72. PubMed ID: 19015633
    [Abstract] [Full Text] [Related]

  • 2. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.
    Oncogene; 1999 Apr 08; 18(14):2381-6. PubMed ID: 10327059
    [Abstract] [Full Text] [Related]

  • 3. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M.
    Oncogene; 1996 Sep 05; 13(5):1027-35. PubMed ID: 8806692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B.
    Cancer Epidemiol Biomarkers Prev; 1996 May 05; 5(5):329-35. PubMed ID: 9162297
    [Abstract] [Full Text] [Related]

  • 7. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 05; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 8. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J, Yu X, Dong J, Zhao W, Zhou Y, Luan Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 05; 11(3):271-3. PubMed ID: 15617346
    [Abstract] [Full Text] [Related]

  • 9. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ, Kessis TD, Chen AW, Han SM, Hedrick L, Cho KR.
    Virology; 1995 Apr 01; 208(1):111-20. PubMed ID: 11831691
    [Abstract] [Full Text] [Related]

  • 10. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
    Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K, Yoshinouchi M.
    Cancer Gene Ther; 2008 Mar 01; 15(3):140-53. PubMed ID: 18157144
    [Abstract] [Full Text] [Related]

  • 11. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS.
    Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug 21; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 13. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.
    Liu Y, Heilman SA, Illanes D, Sluder G, Chen JJ.
    Cancer Res; 2007 Mar 15; 67(6):2603-10. PubMed ID: 17363579
    [Abstract] [Full Text] [Related]

  • 14. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T, Sasaki C, Weinberger P, Psyrri A.
    J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448
    [Abstract] [Full Text] [Related]

  • 15. The role of TP53 in Cervical carcinogenesis.
    Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I.
    Hum Mutat; 2003 Mar 18; 21(3):307-12. PubMed ID: 12619117
    [Abstract] [Full Text] [Related]

  • 16. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM, Dantur KI, Smal C, Pietrasanta L, de Prat-Gay G.
    Biochemistry; 2007 Jan 16; 46(2):341-9. PubMed ID: 17209544
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells.
    Bañuelos A, Reyes E, Ocadiz R, Alvarez E, Moreno M, Monroy A, Gariglio P.
    J Pharmacol Exp Ther; 2003 Aug 16; 306(2):671-80. PubMed ID: 12750435
    [Abstract] [Full Text] [Related]

  • 19. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E.
    Gynecol Oncol; 2004 Jul 16; 94(1):40-7. PubMed ID: 15262117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.